A world leader in pharmaceutical development
Akela Pharma has emerged as one of the world leaders for inhaled therapeutics.Its pipeline includes inhalation therapies for pain management, growth hormone deficiencies, asthma and abuse deterrent formulations.
The Annual General Meeting of Shareholders will take place Friday June 27, 2008 at the Omni Hotel, Salon Été, 1050 Sherbrooke West, Montreal, at 10.30am
